Circulating Tumor Antigens and their Autoantibody Reactivity as Cancer Markers Samir Hanash, Program Head, Fred Hutchinson Cancer Research Center, speaking at CellTech 2013.
Regulation of antibody immunotherapy by fine-tuning FcR interactions Mark Cragg, Southampton University School of Medicine, speaking at Stem Cells & Bioprocessing 2012.
Immunogenicity Assessment for the Successful Development of Biosimilars Dr Michael Tovey, Institut Andre Lwoff/INSERM, speaking at Stem Cells & Bioprocessing 2012.
Bicyclic Peptides with Antibody-Like Binding Affinity and Specificity Dr Vanessa Baeriswyl, EPFL, speaking at Stem Cells & Bioprocessing Europe 2012.
Proteomic Identification of Putative Biomarkers of Radiotherapy Resistance Lynn Cawkwell, University of Hull, speaking at Systems Biology Europe 2012
Antigen Microarrays for Proteomic Profiling of the Autoimmunity Repertoire Professor Peter Nilsson, Royal Institute of Technology, Stockholm, speaking at Advances in Microarray Technology 2012.
Electrochemical and Optical Multiple Parameters Genosensors: Tools for Disease Predisposition Analysis Valerio Beni, Linkoping University, speaking at Advances in Biodetection and Biosensors 2012.
Genomic and Proteomic Biomarkers for Cardiac and Renal Transplantation: Computational Biomarker Pipeline from Discovery to Clinical Implementation Dr. Robert McMaster, Professor, University of British Columbia, speaking at Genomics Research 2012.
Towards a Disease-specific Biomarker Signature for Neuromuscular Disorders Professor Kay Ohlendieck, National University of Ireland, speaking at Molecular Diagnostics Europe 2012.